iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE – Get Free Report) was the target of a large growth in short interest in February. As of February 27th, there was short interest totaling 24,607 shares, a growth of 23.3% from the February 12th total of 19,961 shares. Approximately 1.6% of the company’s stock are short sold. Based on an average trading volume of 16,015 shares, the days-to-cover ratio is presently 1.5 days. Based on an average trading volume of 16,015 shares, the days-to-cover ratio is presently 1.5 days. Approximately 1.6% of the company’s stock are short sold.
Hedge Funds Weigh In On iShares LifePath Target Date 2045 ETF
Institutional investors have recently added to or reduced their stakes in the company. Geneos Wealth Management Inc. acquired a new stake in iShares LifePath Target Date 2045 ETF during the 1st quarter valued at $34,000. Capital Advisors Ltd. LLC acquired a new position in shares of iShares LifePath Target Date 2045 ETF in the fourth quarter valued at $53,000. Sunbelt Securities Inc. raised its position in shares of iShares LifePath Target Date 2045 ETF by 2,054.5% in the third quarter. Sunbelt Securities Inc. now owns 2,607 shares of the company’s stock valued at $94,000 after purchasing an additional 2,486 shares during the period. Finally, Susquehanna International Group LLP lifted its stake in shares of iShares LifePath Target Date 2045 ETF by 38.4% during the 3rd quarter. Susquehanna International Group LLP now owns 9,001 shares of the company’s stock worth $323,000 after buying an additional 2,496 shares during the last quarter.
iShares LifePath Target Date 2045 ETF Stock Performance
iShares LifePath Target Date 2045 ETF stock traded up $0.16 during midday trading on Tuesday, reaching $36.62. The stock had a trading volume of 21,498 shares, compared to its average volume of 15,294. The stock has a market capitalization of $57.13 million, a P/E ratio of 20.03 and a beta of 0.82. The firm’s fifty day simple moving average is $37.24 and its 200-day simple moving average is $36.50. iShares LifePath Target Date 2045 ETF has a 1-year low of $27.42 and a 1-year high of $38.24.
About iShares LifePath Target Date 2045 ETF
The iShares LifePath Target Date 2045 ETF USD (ITDE) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2045 ITDE was launched on Oct 17, 2023 and is issued by BlackRock.
Featured Articles
Receive News & Ratings for iShares LifePath Target Date 2045 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2045 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
